Navigation Links
The Oncologist Pays Tribute to Dr. Judah Folkman
Date:2/27/2008

Pioneering Discoveries Led to Angiogenesis-Inhibiting Drugs for Cancer

Treatment

DURHAM, N.C., Feb. 27 /PRNewswire/ -- The February issue of The Oncologist presents a special tribute to the late Judah Folkman, M.D. -- a legendary surgeon and researcher whose scientific insight led to the development of an entirely new class of drugs for the treatment of cancers.

Dr. Folkman was best known for his work in discovering the importance of new blood vessel formation -- a process called angiogenesis -- for the growth of cancers. His discoveries led to the development of medications called angiogenesis inhibitors, which today are among the most promising new cancer treatments. At the time of his death in January, Dr. Folkman was the Julia Dyckman Andrus Professor of Pediatric Surgery and professor of cell biology at Harvard Medical School, and Director of the Vascular Biology Program at Children's Hospital Boston.

In this month's special tribute, leading scientists and physicians share recollections honoring Dr. Folkman's scientific vision, energy, and compassion. Their essays highlight Dr. Folkman's determination in his twenty- year fight against disbelief in the possibilities of anti-angiogenesis treatment for cancer. "He was patient and persevered on the road to his goal, never neglecting the rules of good science," writes Dr. H.M. Pinedo of VUmc Cancer Center, Amsterdam.

Today, more than one million patients have received some form of angiogenesis inhibitor therapy, estimates Dr. Bruce Chabner of Harvard Medical School and Massachusetts General Hospital, and Editor-in-Chief of "The Oncologist." In addition, over a thousand laboratories are working to explore the concept further. Future research will help to clarify the best uses of angiogenesis inhibitor therapy, and to develop new medications that are more effective and safer -- and perhaps one day, useful in preventing cancers in patients at high risk.

The essayists also honor Dr. Folkman's valued skills as an educator and lecturer -- his frequent talks at scientific meetings were greeted with standing-room-only crowds and standing ovations, writes Dr. Pinedo. Dr. John E. Niederhuber, Director of the National Cancer Institute, recalls Dr. Folkman's dedication and insight as a member of the National Cancer Advisory Board: "Everyone knew that this distinguished, quiet man spoke only when there was truly something to say." Dr. C. Everett Koop, former U.S. Surgeon General, offers a tribute from the unique perspective of a former surgical tutor to Dr. Folkman.

In addition to honoring his scientific achievements, each of the authors pays tribute to Dr. Folkman's human qualities -- especially his dedication to his patients, students, professional colleagues, and family. Dr. Koop concludes, "No scientific discovery can eclipse Judah Folkman the man: creative and innovative pediatric surgeon, healer in the broadest sense of the word, compassionate physician."

The special tribute appears in the February issue of "The Oncolgist," and is available online at: http://theoncologist.alphamedpress.org/cgi/content/full/13/2/205.

About AlphaMed Press

AlphaMed Press publishes the internationally renowned journals, "Stem Cells" and "The Oncologist." "Stem Cells," now in its 26th year, is the oldest and one of the world's top-tier peer-reviewed monthly journals in the fast-paced area of stem cells and regenerative medicine. "The Oncologist," in its 13th year, is a premier peer-reviewed monthly journal dedicated to physicians entrusted with the care of cancer patients. View AlphaMed Press journals at http://www.alphamedpress.org.

Contact: George Kendall: 919-680-0011, GKendall@alphamedpress.com.


'/>"/>
SOURCE AlphaMed Press
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
2. Jefferson radiation oncologists use real-time system to plant seeds against cancer
3. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
4. Leading Oncologists from Across the Country Hold Emergency Meeting on New Government Reimbursement Policy for Medicare Patients with Cancer
5. Jefferson oncologists show focused radiation is effective as surgery against nerve tumor
6. Expert Neurosurgeons and Neuro-oncologists to Speak at 6th Annual Brain Tumor Awareness Day Convention
7. 91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs
8. Society of Gynecologic Oncologists to Host 39th Annual Meeting on Womens Cancer
9. Despite Oncologists Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23
10. Adverse housing conditions contribute to diabetes risk
11. Infection contributes to the high rates of oropharyngeal cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing in ... post on insurance options. If a Bay Area patient has to search for a ... money. Visiting an in-network provider for a second opinion can ensure a patient receives ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Just What Happened in the Garden of Eden”: retells ... Garden of Eden” is the creation of published author, Penelope Colt, mother, trader, horse farmer, ... moved to NYC when she was three. At six, they moved to Dayton, Ohio, ...
(Date:5/24/2017)... ... May 24, 2017 , ... In modern research, ... most appropriate instruments for research and understanding the basic principles that were designed ... focus on innovations in stereo microscopy for brightfield and fluorescence typically used in ...
(Date:5/24/2017)... ... May 24, 2017 , ... Drs. Nicholas Rallis and ... now spent 10 years as clinical instructors for the reputable Full Mouth Rehabilitation ... Through the program, private practitioners receive cutting-edge clinical training and learn how to ...
(Date:5/24/2017)... , ... May 24, 2017 , ... Myers Jackson is ... has the ability to sell luxury homes anywhere on the planet. The luxury home ... side from Hattiesburg to Houston city-scapes. A quick search of “11 Spyglass Hill Auction ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based in ... Parkinson,s disease (PD), has enrolled the first patient in the ... multicenter study involving patients with PD and taking place at ... 9-to-12-month period. The first stage is open label and involves ... include Denver , Boca Raton ...
(Date:5/10/2017)... , May 10, 2017  The Corporate ... or employees of sleep therapy clinics to call ... sleep therapy clinic is involved in a substantial ... interested in hearing from an employee of a ... in a kickback scheme to provide medical practice groups ...
(Date:5/9/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... on the development of oral drug delivery systems, ... has granted Oramed a patent titled, "Methods and ... covers Oramed,s invention of an oral glucagon-like peptide-1 ... hormone that stimulates the secretion of insulin from ...
Breaking Medicine Technology: